Latest news
Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera - aijourn.comaijourn.com · Mon, 10 Aug 2026 03:14:10 GMTSilence Therapeutics PLC (SLN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTSilence Therapeutics PLC (SLN) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTAnalysts Have Conflicting Sentiments on These Healthcare Companies: Vericel (VCEL) and Silence Therapeutics (SLN) - The Globe and MailThe Globe and Mail · Thu, 30 Jul 2026 06:10:00 GMT